Aurora Spine receives two U.S. patents

Executive Summary

• Aurora Spine Corp. announced the issuance of two new U.S. patents from the U.S. Patent and Trademark Office, expanding its protected intellectual property portfolio.
• The patents cover the company's flagship ZIP implant family and introduce a data-driven methodology for matching orthopedic implants to patient bone density scans.
• The simultaneous issuance reinforces Aurora Spine's long-term innovation strategy, clinical differentiation, and enforceable IP position in the spine surgery market.

Key Details

• Patent 1: U.S. Patent No. 12,478,411 B2, titled "Spinal Implant for Motion Preservation or Fusion". Represents the 10th issued U.S. patent for the ZIP implant family. Covers an implant architecture designed to support either motion preservation or fusion, featuring multiple interacting structural components that distribute load and engage progressively under physiological forces.
• Patent 2: U.S. Patent No. 12,478,481 B2, titled "Bone Density Scan Result-Matched Orthopedic Implants and Methods of Use". Protects a structured, data-driven framework enabling surgeons to utilize objective bone density data (e.g., DEXA) to guide implant selection and match implant characteristics to patient bone quality. Forms the basis of Aurora Spine's DEXA technology platform (3rd bone-density-matched implant system patent).
• Both patents are now issued and fully enforceable in the United States.
• The issuance underscores the company's continued investment in diverse, non-overlapping innovation pathways to support future product development, clinical differentiation, and long-term shareholder value.

Notable Quotes

• Trent J. Northcutt, President and CEO: "The issuance of the tenth patent for the ZIP implant family highlights the strength, longevity and originality of this platform... ZIP has been a foundational technology for our company, and this milestone further reinforces our ability to protect and evolve solutions that address real biomechanical and clinical challenges in spine surgery."
• Laszlo Garamszegi, Chief Technology Officer and Co-Founder: "Bone quality is one of the most important variables in spine surgery, yet it has historically been underutilized in implant selection... This patent establishes a formal, repeatable method for aligning implant selection with patient bone characteristics using objective data."